| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCN | Common Stock | Options Exercise | $114,887 | +3,116 | +1% | $36.87 | 308,929 | 29 Feb 2024 | Direct | |
| transaction | FCN | Common Stock | Options Exercise | $132,437 | +3,592 | +1.2% | $36.87 | 312,521 | 01 Mar 2024 | Direct | |
| transaction | FCN | Common Stock | Sale | $655,232 | -3,116 | -1% | $210.28 | 309,405 | 29 Feb 2024 | Direct | F1 |
| transaction | FCN | Common Stock | Sale | $736,576 | -3,592 | -1.2% | $205.06 | 305,813 | 01 Mar 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCN | Stock Option (right to buy) | Options Exercise | $0 | -3,116 | -1.6% | $0.000000 | 190,064 | 29 Feb 2024 | Common Stock | 3,116 | $36.87 | Direct | F3 |
| transaction | FCN | Stock Option (right to buy) | Options Exercise | $0 | -3,592 | -1.9% | $0.000000 | 186,472 | 01 Mar 2024 | Common Stock | 3,592 | $36.87 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On February 29, 2024, Mr. Gunby sold an aggregate of 3,116 shares of FTI Consulting, Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $210.25 to $210.38. The Company maintains a record of the transactions and copies will be provided upon request. |
| F2 | On March 1, 2024, Mr. Gunby sold an aggregate of 3,592 shares of FTI Consulting, Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $204.75 to $205.46. The Company maintains a record of the transactions and copies will be provided upon request. |
| F3 | All options pursuant to these awards vested and became exercisable in full on March 1, 2018. |